Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.6 USD | -0.75% | +1.08% | +8.78% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company benefits from high valuations in earnings multiples.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.78% | 1.62B | B- | ||
+1.22% | 77.72B | B | ||
+0.96% | 32.51B | C | ||
+8.75% | 18.21B | B | ||
-9.28% | 11.6B | B | ||
+8.55% | 11.28B | A- | ||
-2.33% | 9.94B | - | ||
+5.97% | 9.92B | A- | ||
+3.48% | 9.48B | C- | ||
+4.24% | 8.33B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HWKN Stock
- Ratings Hawkins, Inc.